CVE-2026-34324 Missing authorization in Oracle Life Sciences InForm

Medium 6.5 Published 21 Apr 2026 Updated 22 Apr 2026

Unauthenticated attackers can read and modify clinical trial data via HTTP due to missing authorization checks in Oracle Life Sciences InForm.

Exploited in the wild: Not known
Login needed: Not needed
Attackable: Over the internet
Victim action needed: Not needed
Fix: None listed

What is CVE-2026-34324?

CVE-2026-34324 is a medium-severity missing authorization vulnerability in Oracle Life Sciences InForm, published on 21 Apr 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.

Official description

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Weakness: CWE-284

Which versions are affected by CVE-2026-34324?

It affects 1 product.

Products include Oracle Life Sciences Inform.

How do I fix CVE-2026-34324?

No fix has been published for CVE-2026-34324 yet. Limit exposure of the affected software until one is available.

Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.

Is CVE-2026-34324 being exploited?

There is no known exploitation of CVE-2026-34324 in the wild and no public exploit code.

Sources

Also known as GHSA-cj86-2v89-gm24.